Resultados de la búsqueda 471-480 of 13831 for Raynaud phenomenon
Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from ...
Raynaud's. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/raynaud/. Accessed March 6, 2015. Buerger disease.
A biomarker is a measurable indicator of the severity or presence of disease state. Information collected in this study may help doctors to develop new ...
Mayo Clinic Cardiovascular Disease Biobank. Rochester, Minn. The purpose of this study is to determine the innate immune, cell death and oxidative stress ...
... disease. Minnesota Spinal Cord Injury Data Network. Rochester, Minn. This is ... disease following an attempt to perform definitive treatment (including ...
Jacksonville, Fla. The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an ...
ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.
Rochester, Minn. The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive ...
Jacksonville, Fla. The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...
Evaluating Optic Nerve Disease with OCT Angiography ... Rochester, Minn. The purpose of this study is to determine if optical coherence tomography (OCT) ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?